Track 2: Innovative drug discovery and access

Innovation is revolutionising health care, and this congress track explores the role of pharmacists in the era of innovative drug discovery and access. The convergence of science, digitalisation and technology is shaping a brighter future.

Scientific breakthroughs are driving transformation, with pharmaceutical research and biotechnology advancements paving the way for cutting-edge therapies. Precision medicine tailors treatments to individual patients, marking a significant stride in personalised health care.

Digitalisation has permeated the pharmaceutical industry, revolutionising the distribution of medicines and logistics of medication. Cell and gene therapies along with new medicines now reach patients faster and safer, facilitated by advanced digital systems and thermal packaging.

Addressing global health challenges, particularly in the fight against non-communicable diseases, including cancer, involves patient-centred trials with active pharmacist involvement. Ethical supply chains and circular economy principles are now industry standards, fostering sustainability from drug development to distribution.

Digital health technologies play a pivotal role in drug development, utilising real-world data and digital tools to inform every stage of the process. Regulatory bodies also recognise the importance of facilitating innovation while ensuring patient safety and access to medicines. A collaborative approach streamlines the path from drug discovery to market approval. A data-driven approach not only accelerates drug development but also enhances affordability, making life-changing therapies more accessible.

The narrative of innovative drug discovery and access is one of hope and progress, where science, technology and the dedication of healthcare professionals converge to unlock new possibilities. It stands as a testament to the achievements made possible when daring to dream and innovating for the betterment of health care for all.

Access to medicines is recognised as a fundamental right. Initiatives like drug access programmes and pricing transparency measures are ensuring affordability, while accessible clinical trials offer opportunities for diverse patient populations to participate in research. In this era of innovation, pharmacists play a central role in co-creating health care. Their expertise in pharmaco-economics, global partnerships and open-access drug research makes them invaluable contributors to the industry.